This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42751053
rdf:type
wikibase:Item
schema:description
2011年論文 2011年论文 article scientific articolo scientifico 2011年論文 scientific article published on March 2011 2011 nî lūn-bûn 2011年论文 artigo científico videnskabelig artikel artigo científico επιστημονικό άρθρο tudományos cikk 2011년 논문 article científic научни чланак 2011年論文 2011年の論文 2011年论文 artículo científico publicado en 2011 наукова стаття, опублікована в березні 2011 wissenschaftlicher Artikel vedecký článok 2011年论文 naučni članak মার্চ ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научная статья artikulong pang-agham vitskapeleg artikkel articol științific 2011年論文 wetenschappelijk artikel scientific article published on March 2011 artículu científicu espublizáu en 2011 2011年论文 2011年論文 2011年论文 vetenskaplig artikel სამეცნიერო სტატია научни чланак מאמר מדעי scientific article published on March 2011 article scientifique bilimsel makale artigo científico บทความทางวิทยาศาสตร์ artikel ilmiah teaduslik artikkel مقالة علمية نشرت في مارس 2011 мақолаи илмӣ tieteellinen artikkeli artykuł naukowy научна статия vitenskapelig artikkel artikull shkencor vědecký článek bài báo khoa học scienca artikolo
p:P577
wds:Q42751053-2B934784-B0A6-4127-A31B-6207F9E6D5BF
wdt:P577
2011-03-01T00:00:00Z
p:P2860
wds:Q42751053-90934814-D697-47BE-B62C-A40B9C74BC8F wds:Q42751053-93E1C72C-DC09-45BF-8E1E-9D507EC987CC wds:Q42751053-4773D346-346F-441D-9758-E84178E58070 wds:Q42751053-4CD8D327-CC30-4740-830A-0B3CEA63E9A6 wds:Q42751053-508C55C3-4AC1-4CB6-9263-6780293771CC wds:Q42751053-5285A20C-E69B-41BB-A06C-A3CE968CFB2D wds:Q42751053-56391AFE-CD72-4B71-9F7C-35EE605EF540 wds:Q42751053-5E1BFFEA-264B-4A43-8FDA-6DF234D4CB8F wds:Q42751053-5E8E56B7-B33E-4526-A02F-42F6932F792F wds:Q42751053-0B299678-D7EB-43AF-9D34-4751695C8D71 wds:Q42751053-3A7F116B-EF23-40A9-850C-E00F33DF2DFA wds:Q42751053-41AB591C-2EBA-44C5-B927-977CCF62B23A wds:Q42751053-DCCFB4A3-F7F2-4F9B-AFC6-D4F7D53B9298 wds:Q42751053-F7290CB2-4493-4B37-8AE2-2DFCE7402B52 wds:Q42751053-A0DF8E11-DAC9-428E-95F0-30A34927FAA6 wds:Q42751053-C52817B7-D557-4D93-BB8B-B776B1111160 wds:Q42751053-C7FC3392-1EB8-48F0-AE77-51E14AF4BFD4 wds:Q42751053-7249D2BD-D688-4189-9F33-0886E3FE99CC
wdt:P2860
wd:Q37484685 wd:Q30432945 wd:Q42959494 wd:Q46562549 wd:Q40169268 wd:Q48666967 wd:Q57529701 wd:Q30306766 wd:Q24657796 wd:Q37261901 wd:Q80609871 wd:Q37565218 wd:Q52881733 wd:Q46334842 wd:Q79607646 wd:Q37565205 wd:Q34756419 wd:Q44545760
p:P2093
wds:Q42751053-F5042CD4-F2B6-4687-80E0-66D917997F2B wds:Q42751053-DE05098E-8E13-4C7E-8193-44DA4F755F4C wds:Q42751053-CD294562-347D-4782-BB8B-299CCEAECDD9 wds:Q42751053-AEAD641D-2DD7-4CAC-A842-8B9A019358E6 wds:Q42751053-AD865C7C-1494-4A4A-8495-5B44E8EBDDC2 wds:Q42751053-A6D26F4E-056B-4DD0-A4C6-A1190AF736E4 wds:Q42751053-45DD5A37-1815-410E-9338-03A2D1678A47
wdt:P2093
Vincent Mok Susan Huyck Kenneth Wolski Federico Micheli Emmanuelle Pourcher Marco Onofrj Marc Cantillon
rdfs:label
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
skos:prefLabel
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
schema:name
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
p:P50
wds:Q42751053-996CB516-6DFF-4061-A9BA-D909CB1B23C3
wdt:P50
wd:Q64855796
p:P1476
wds:Q42751053-750529CC-48E3-4BA1-859C-E8E3E45B8B20
wdt:P1476
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
p:P304
wds:Q42751053-CE4BE297-B763-4431-B821-9C162327C148
wdt:P304
221-229
p:P31
wds:Q42751053-F9A92346-C38A-4CE8-82A0-E35AFD419732
wdt:P31
wd:Q13442814
p:P921
wds:Q42751053-35556EA6-10F2-4CA1-83BC-6E34B1188281 wds:Q42751053-5521299E-74AB-4838-84D2-E9E9D00E0E34
wdt:P921
wd:Q11085 wd:Q42824440
p:P698
wds:Q42751053-7D621012-B041-4496-93A9-90DF8F4BB150
wdtn:P698
n12:21315654
wdt:P698
21315654
p:P1433
wds:Q42751053-C9DA9B3E-C41F-4D60-B4DB-A8900821A4EF
wdt:P1433
wd:Q15755067
p:P433
wds:Q42751053-8A40E89F-25C2-42F1-BFE5-5DA6A81FD859
p:P478
wds:Q42751053-959DE49B-69DA-46B8-9498-EBE51BCE46DF
wdt:P433
3
wdt:P478
10
p:P356
wds:Q42751053-E50289C0-5146-4EDA-BC4C-240706A11DD1
wdtn:P356
n9:S1474-4422(11)70012-6
wdt:P356
10.1016/S1474-4422(11)70012-6
p:P8608
wds:Q42751053-A765187E-15B3-455C-B5FC-85675E4018B5
wdt:P8608
release_iwrw75ufdjctpa2iguocnwhbuu